NEXUS ASTRAIA B.V.

Nexus Astraia B.V. specializes in fetal monitoring devices. Specifically, they produce the Mosos CTG, which is designed for continuous cardiotocography (CTG) to monitor fetal heart rate and uterine contractions during pregnancy and labor. This device helps healthcare providers assess fetal well-being in real-time.

Nexus Astraia B.V. is based in the Netherlands. The company operates within the country while also providing support for its software solutions through local partners like Sorg-Saem in the Benelux region and directly via its website for international customers.

The Mosos CTG, Nexus Astraia B.V.’s primary device, is listed in the EU’s eudamed registry. This registry is used to track medical devices that have been authorized for placement on the European market, ensuring transparency and traceability.

The Mosos CTG is classified as a Class IIb medical device under EU regulations. This classification is determined based on the device’s intended purpose and potential risks. Class IIb devices are considered to have a moderate risk and require additional scrutiny, including conformity assessment procedures, to ensure their safety and performance.